Christophe Hermans

1.0k citations

32 papers · 649 indexed · h-index 16

Co-authors: Christophe Deben Marc Peeters Evelien Smits Patrick Pauwels Filip Lardon Julie Jacobs Vanessa Deschoolmeester Hilde Lambrechts
Topics: Cancer Immunotherapy and Biomarkers (8 papers)Cancer Genomics and Diagnostics (4 papers)Ferroptosis and cancer prognosis (3 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Blood Cancer Research Frontiers in Immunology
Partner nations: Belgium Netherlands Spain

In The Last Decade

Christophe Hermans

31 papers receiving 630 citations

Peers

Countries citing papers authored by Christophe Hermans

Since Specialization

Citations

This map shows the geographic impact of Christophe Hermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Hermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Hermans more than expected).

Fields of papers citing papers by Christophe Hermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Hermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Hermans. The network helps show where Christophe Hermans may publish in the future.

Co-authorship network of co-authors of Christophe Hermans

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Hermans. A scholar is included among the top collaborators of Christophe Hermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Hermans. Christophe Hermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma 2025 ·OncoImmunology ·(unknown),Jonas R.M. Van Audenaerde,(unknown),Jorrit De Waele,(unknown),Christophe Hermans,(unknown),Céline Merlin,Maria Ribas,Peter Ponsaerts,Steven Van Laere,Filip Lardon,An Wouters,Scott Fisher,Jan P. van Meerbeeck,Elly Marcq,Evelien Smits	0
2	Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer 2023 ·npj Precision Oncology ·(unknown),Edgar Cardenas De La Hoz,(unknown),(unknown),Christophe Hermans,Andreas Domen,Evelien Smits,Filip Lardon,Timon Vandamme,Abraham Lin,Steve Vanlanduit,Geert Roeyen,Steven Van Laere,Hans Prenen,Marc Peeters,Christophe Deben	15
3	Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers 2023 ·Antioxidants ·Laurie Freire Boullosa,Jinthe Van Loenhout,Tal Flieswasser,Christophe Hermans,Céline Merlin,(unknown),Elly Marcq,Marlies Verschuuren,Winnok H. De Vos,Filip Lardon,Evelien Smits,Christophe Deben	16
4	Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity 2023 ·Cancer Drug Resistance ·(unknown),Ines De Pauw,(unknown),(unknown),(unknown),Christophe Hermans,(unknown),Hilde Lambrechts,Céline Merlin,Cyril Corbet,Marc Peeters,Jan B. Vermorken,Jorrit De Waele,Filip Lardon,An Wouters	2
5	Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer 2023 ·OncoImmunology ·Tal Flieswasser,(unknown),Laurie Freire Boullosa,(unknown),Christophe Hermans,Céline Merlin,(unknown),Jonas R.M. Van Audenaerde,Filip Lardon,Evelien Smits,Patrick Pauwels,Julie Jacobs	6
6	The prognostic impact of the immune signature in head and neck squamous cell carcinoma 2022 ·Frontiers in Immunology ·(unknown),Vasiliki Siozopoulou,(unknown),Christophe Hermans,(unknown),Hilde Lambrechts,Erik Fransén,Ines De Pauw,Julie Jacobs,Marc Peeters,Patrick Pauwels,Jan B. Vermorken,Evelien Smits,Filip Lardon,Jorrit De Waele,An Wouters	13
7	Prognostic implications of cellular senescence in resected non-small cell lung cancer 2022 ·Translational Lung Cancer Research ·Andreas Domen,Christophe Deben,Ines De Pauw,Christophe Hermans,Hilde Lambrechts,(unknown),Vasiliki Siozopoulou,Patrick Pauwels,Marco Demaria,(unknown),Annelies Janssens,Jeroen Hendriks,Paul Van Schil,Jan B. Vermorken,Timon Vandamme,Hans Prenen,Marc Peeters,Filip Lardon,An Wouters	29
8	Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model 2022 ·Pharmaceutics ·Laurie Freire Boullosa,Jinthe Van Loenhout,Christophe Hermans,(unknown),Céline Merlin,Elly Marcq,(unknown),Wim Martinet,Guido R.Y. De Meyer,Filip Lardon,Evelien Smits,Christophe Deben	7
9	Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer 2021 ·Redox Biology ·Laurie Freire Boullosa,Jinthe Van Loenhout,Tal Flieswasser,Jorrit De Waele,Christophe Hermans,Hilde Lambrechts,Bart Cuypers,Kris Laukens,Esther Bartholomeus,Vasiliki Siozopoulou,Winnok H. De Vos,Marc Peeters,Evelien Smits,Christophe Deben	85
10	Efficacy and histopathological effects of self-assembling peptides RADA16 and IEIK13 in neurosurgical hemostasis 2021 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown),Martin Lammens,Vincent Van Rompaey,(unknown),Krystyna Szewczyk,Christophe Hermans,Tomas Menovsky	5
11	Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients 2020 ·Cancers ·(unknown),Julie Jacobs,Christophe Deben,Christophe Hermans,Glenn Broeckx,Evelien Smits,Evelyne Maes,Jo Raskin,Patrick Pauwels,Geert Baggerman	19
12	Delineation of a new fibrillin-2-opathy with evidence for a role of FBN2 in the pathogenesis of carpal tunnel syndrome 2020 ·Journal of Medical Genetics ·(unknown),(unknown),Stuart A. Cain,Peter Houpt,Frederik Verstreken,(unknown),Christophe Hermans,Werner Jacobs,Martin Lammens,Erik Fransén,Ajay Kumar,Geert Vandeweyer,Bart Loeys,Wim Van Hul,Clair Baldock,Eveline Boudin,Geert Mortier	7
13	Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression 2019 ·Cancer Immunology Immunotherapy ·Vasiliki Siozopoulou,Elly Marcq,Julie Jacobs,Karen Zwaenepoel,Christophe Hermans,(unknown),(unknown),Clément J.R. Huysentruyt,Martin Lammens,Johan Somville,Evelien Smits,Patrick Pauwels	14
14	In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53 2019 ·Molecular Oncology ·Jolien Van den Bossche,Christophe Deben,Ines De Pauw,Hilde Lambrechts,Christophe Hermans,Vanessa Deschoolmeester,Julie Jacobs,Pol Specenier,Patrick Pauwels,Jan B. Vermorken,Marc Peeters,Filip Lardon,An Wouters	15
15	Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation 2018 ·OncoImmunology ·Julie Jacobs,Vanessa Deschoolmeester,Karen Zwaenepoel,Tal Flieswasser,Christophe Deben,Jolien Van den Bossche,Christophe Hermans,Christian Rolfo,Marc Peeters,Olivier De Wever,Filip Lardon,Vasiliki Siozopoulou,Evelien Smits,Patrick Pauwels	45
16	Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients 2018 ·Clinical Colorectal Cancer ·Nele Boeckx,Ken Op de Beeck,Matthias Beyens,Vanessa Deschoolmeester,Christophe Hermans,(unknown),Sonia Garrigou,Corinne Normand,Els Monsaert,Konstantinos Papadimitriou,Pierre Laurent‐Puig,Patrick Pauwels,Guy Van Camp,Valérie Taly,Marc Peeters	39
17	Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia 2017 ·Journal of Cancer ·Jolien Van den Bossche,Christophe Deben,Ken Op de Beeck,Vanessa Deschoolmeester,Christophe Hermans,Ines De Pauw,Julie Jacobs,Paul Van Schil,Jan B. Vermorken,Patrick Pauwels,Marc Peeters,Filip Lardon,An Wouters	12
18	Bone Marrow Stroma Damage Induced by Chemotherapy for Acute Lymphoblastic Leukemia in Children 2003 ·Pediatric Research ·Francis Corazza,Christophe Hermans,Alina Ferster,Pierre Fondu,Anne Demulder,Eric Sariban	21
19	Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer 2003 ·European Journal of Cancer ·Christian Dittrich,Bruno Coudert,Luis Paz‐Ares,Francesco Caponigro,Marc Salzberg,Teresa Gamucci,Xavier Paolettí,Christophe Hermans,Didier Lacombe,P. Fumoleau	25
20	Priming solutions for cardiopulmonary bypass: Comparison of three colloids 1991 ·Journal of Cardiothoracic and Vascular Anesthesia ·D. Himpe,(unknown),Hedwig Neels,(unknown),(unknown),(unknown),(unknown),Christophe Hermans,Godelieve Goossens,(unknown),Johan Van Hoof,(unknown),H. Adriàensen	35

About Christophe Hermans

Christophe Hermans is a scholar working on Oncology, Cancer Research and Microbiology, having authored 32 papers that have together received 649 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (4 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Oncology (230 citations), Cancer Research (118 citations) and Immunology (139 citations). Christophe Hermans has collaborated with scholars based in Belgium, Netherlands and Spain. Frequent co-authors include Christophe Deben, Marc Peeters, Evelien Smits, Patrick Pauwels, Filip Lardon, Julie Jacobs, Vanessa Deschoolmeester, Hilde Lambrechts, Vasiliki Siozopoulou and Jinthe Van Loenhout. Their work appears in journals such as Blood, Cancer Research and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact